Kaiser Permanente
Kaiser Permanente is a private, non-profit integrated managed care consortium headquartered at 1 Kaiser Plaza, Oakland, California, United States, and founded in 1945. It is not publicly listed and has no ticker; ownership combines Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals (including Risant Health), and the Permanente Medical Groups. For fiscal year 2025, Kaiser Permanente reported revenue of US$127.7 billion and net income of US$9.3 billion. Scale facts include revenue growth from US$88.7 billion in 2020 to US$127.7 billion in 2025, and 2024 net income of US$12.9 billion.
Strengths: Kaiser Permanente's integrated managed care structure aligns health plan, hospitals, and Permanente Medical Groups, supporting coordinated care and a broad membership proposition. Its brand set including Risant Health, Geisinger Health, and Cone Health adds care and health-system channels. Revenue rose from US$88.7 billion in 2020 to US$127.7 billion in 2025, and net income was positive in four of five years from 2021 through 2025, including US$9.3 billion in 2025.
Weaknesses: Kaiser Permanente's 2022 net loss of US$4.47 billion shows earnings volatility, and net income fell from US$12.9 billion in 2024 to US$9.3 billion in 2025. As a private non-profit consortium with no public shares or market capitalization, Kaiser Permanente offers limited public-market valuation and share-price transparency. The company filings also omits assets, headcount, country coverage, and segment revenue mix, limiting external scale and diversification analysis.
Read MoreShow Less
Kaiser Permanente is a private, non-profit integrated managed care consortium headquartered at 1 Kaiser Plaza, Oakland, California, United States, and founded in 1945. It is not publicly listed and has no ticker; ownership combines Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals (including Risant Health), and the Permanente Medical Groups. For fiscal year 2025, Kaiser Permanente reported revenue of US$127.7 billion and net income of US$9.3 billion. Scale facts include revenue growth from US$88.7 billion in 2020 to US$127.7 billion in 2025, and 2024 net income of US$12.9 billion.
Strengths: Kaiser Permanente's integrated managed care structure aligns health plan, hospitals, and Permanente Medical Groups, supporting coordinated care and a broad membership proposition. Its brand set including Risant Health, Geisinger Health, and Cone Health adds care and health-system channels. Revenue rose from US$88.7 billion in 2020 to US$127.7 billion in 2025, and net income was positive in four of five years from 2021 through 2025, including US$9.3 billion in 2025.
Weaknesses: Kaiser Permanente's 2022 net loss of US$4.47 billion shows earnings volatility, and net income fell from US$12.9 billion in 2024 to US$9.3 billion in 2025. As a private non-profit consortium with no public shares or market capitalization, Kaiser Permanente offers limited public-market valuation and share-price transparency. The company filings also omits assets, headcount, country coverage, and segment revenue mix, limiting external scale and diversification analysis.
In the press
All coverage →3 latest headlines3- Kaiser Permanente and Risant Health Report 2025 Financial Results with $127.7 Billion in Operating Revenues and $9.3 Billion Net Incomeabout.kaiserpermanente.org2026-02-01
- Kaiser Permanente Edges Operating Margins Higher in 2025 as Risant Health Bolsters Financial Profilehealthleadersmedia.com2026-02-01
- Kaiser Permanente Closes 2025 with $9.3B Bottom Line Buoyed by $7.9B in Investment Incomefiercehealthcare.com2026-02-01
• Founded 1945; HQ 1 Kaiser Plaza, Oakland, CA 94612, US
• Private non-profit integrated managed care consortium
• Comprises Kaiser Foundation Health Plan, Kaiser Foundation Hospitals incl. Risant Health and Permanente Medical Groups
Portfolio – brands
• Kaiser Foundation Health Plan; Kaiser Foundation Hospitals
• Permanente Medical Groups deliver physician care
• Risant Health brands: Geisinger Health, Cone Health
Financials – revenue
• 2020: US$88.7bn; 2021: US$93.1bn; 2022: US$95.4bn
• 2023: US$100.8bn; 2024: US$115.8bn; 2025: US$127.7bn
• All figures USD; local revenue equals reported revenue
Financials – net income
• 2020: US$6.4bn; 2021: US$8.1bn net income
• 2022: net loss US$4.47bn; 2023: US$4.12bn
• 2024: US$12.9bn; 2025: US$9.3bn net income
| Fiscal year | Revenue | Net income |
|---|---|---|
| 2025 | $128 B | $9.3 B |
| 2024 | $116 B | $12.9 B |
| 2023 | $101 B | $4.1 B |
| 2022 | $95.4 B | −$4.5 B |
| 2021 | $93.1 B | $8.1 B |
| 2020 | $88.7 B | $6.4 B |
Annual results from company filings (SEC XBRL), converted to US dollars.
Quick Facts
Headquarters
Oakland, United States
Founded
1945
Revenue
US$127.7 B (FY2025)
Factories
Hospitals, clinics and medical offices across multiple US states
Presence
Multiple US states, primarily California
Listing
Private
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website
